Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis

التفاصيل البيبلوغرافية
العنوان: Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis
المؤلفون: Vivian Laquer, Viviana Parra, Jean-Philippe Lacour, Hidetoshi Takahashi, Jack Knorr, Angela J. Okragly, Douglas E. James, Jonathan T. Sims, Ching-Yun Chang, Jeannie Chao, Paul Klekotka
المصدر: British Journal of Dermatology. 187:599-602
بيانات النشر: Oxford University Press (OUP), 2022.
سنة النشر: 2022
مصطلحات موضوعية: Dermatology
تدمد: 1365-2133
0007-0963
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a4dbcc28700962595ae0de478cd7e900
https://doi.org/10.1111/bjd.21631
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........a4dbcc28700962595ae0de478cd7e900
قاعدة البيانات: OpenAIRE